MiRNA-21: a key to controlling the cardiac fibroblast compartment?
Haghikia
Arash
A
Hilfiker-Kleiner
Denise
D
D000818:Animals; D005347:Fibroblasts / Q000201:enzymology* / Q000473:pathology; D020869:Gene Expression Profiling / Q000379:methods; D015971:Gene Expression Regulation, Enzymologic; D006801:Humans; D020778:Matrix Metalloproteinase 2 / Q000235:genetics / Q000378:metabolism; D051379:Mice; D035683:MicroRNAs / Q000378:metabolism*; D009203:Myocardial Infarction / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D015428:Myocardial Reperfusion Injury / Q000201:enzymology / Q000235:genetics* / Q000473:pathology; D051059:PTEN Phosphohydrolase / Q000235:genetics / Q000378:metabolism; D051057:Proto-Oncogene Proteins c-akt / Q000378:metabolism; D013997:Time Factors
C531950:MIRN21 microRNA, mouse; D035683:MicroRNAs; D051057:Proto-Oncogene Proteins c-akt; D051059:PTEN Phosphohydrolase; C487757:Pten protein, mouse; D020778:Matrix Metalloproteinase 2; C522362:Mmp2 protein, mouse